Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India

BACKGROUND: Tenofovir (TDF) is preferred nucleoside reverse transcriptase inhibitors (NRTI) for the treatment of human immunodeficiency virus infection because of its potency and safety. Renal toxicity with TDF use is low and comparable with other NRTI in clinical trials, but there are many case stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Ketan K., Patel, Atul K., Ranjan, Rajiv R., Patel, Apurva R., Patel, Jagdish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140146/
https://www.ncbi.nlm.nih.gov/pubmed/21808434
http://dx.doi.org/10.4103/2589-0557.68998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140146/
https://www.ncbi.nlm.nih.gov/pubmed/21808434
http://dx.doi.org/10.4103/2589-0557.68998

Ejemplares similares